| CYHB1204707 | 盐酸拓扑替康胶囊 | topotecan hydrochloride | Capsule | Chemical Drugs | Supplementary Application | 2012-08-20 | 南京瑞年百思特制药有限公司 | Nanjing Ruinian Bai Si Te Pharmaceutical Co Ltd | Certificate Issued | 2013-07-09 | view |
| CXHS0500716 | 盐酸拓扑替康胶囊 | topotecan hydrochloride | Capsule | Chemical Drugs | New Drug Application | 2005-04-07 | 南京瑞年双科制药有限公司 | Nanjing Ruinian Bai Si Te Pharmaceutical Co Ltd | Certificate Issued | 2007-09-19 | view |
| CXHS0500715 | 盐酸拓扑替康胶囊 | topotecan hydrochloride | Capsule | Chemical Drugs | New Drug Application | 2005-04-07 | 南京瑞年双科制药有限公司 | Nanjing Ruinian Bai Si Te Pharmaceutical Co Ltd | Certificate Issued | 2007-09-19 | view |
| CYHS0900251 | 盐酸拓扑替康 | topotecan hydrochloride | Active ingredient | Chemical Drugs(6) | Generic Drug | 2009-05-27 | 四川科瑞德凯华制药有限公司 | Luzhou Credit Pharmaceutical Co Ltd | Certificate Issued | 2011-07-27 | view |
| CXL01653 | 盐酸托泊替康胶囊 | topotecan hydrochloride | Capsule | Chemical Drugs(4) | New Drug Application | 2001-07-30 | 史克必成（天津）有限公司 | Glaxo Smith Kline Tianjin Co Ltd | | | view |
| CXL01652 | 盐酸托泊替康胶囊 | topotecan hydrochloride | Capsule | Chemical Drugs(4) | New Drug Application | 2001-07-30 | 史克必成（天津）有限公司 | Glaxo Smith Kline Tianjin Co Ltd | Certificate Issued | 2002-02-26 | view |
| B20000175 | 盐酸托泊替康 | topotecan hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2001-02-26 | 史克必成（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| CYHS1100812 | 盐酸托泊替康 | topotecan hydrochloride | Active ingredient | Chemical Drugs(6) | Generic Drug | 2011-11-10 | 山西普德药业股份有限公司 | Shanxi PUDE Pharmaceutical Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXb01084 | 注射用盐酸拓扑替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs(2) | Supplementary Application | 2001-03-16 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Pending Approval | 2001-09-19 | view |
| X0304239 | 注射用盐酸拓扑替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2003-08-13 | 扬州奥赛康药业有限公司 | Yangzhou Aosaikang Pharmaceutical Co Ltd | Certificate Issued | 2004-01-14 | view |
| JXHL0900430 | 注射用盐酸拓扑替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Import Drug Application | 2010-01-04 | 阿特维斯集团贸易有限公司 | Actavis Group | Certificate Issued | 2016-07-25 | view |
| JYHB1701177 | 注射用盐酸拓扑替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2017-09-12 | 上海诺华贸易有限公司 | Shanghai Novartis Trading Ltd | Filed | 2017-09-25 | view |
| JYHB1801388 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2018-11-30 | | | Certificate Issued | 2019-01-18 | view |
| H20020285 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Import Drug Application | 2002-11-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2003-08-15 | view |
| CYHS0900630 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2009-10-10 | 哈尔滨誉衡药业股份有限公司 | Harbin Gloria Pharmaceuticals Co Ltd | Certificate Issued | 2011-12-13 | view |
| JYHB1701055 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2017-08-04 | 上海诺华贸易有限公司 | Shanghai Novartis Trading Ltd | Filed | 2017-08-30 | view |
| JYHB2200571 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs(5.1) | Supplementary Application | 2022-10-24 | | | | | view |
| JYHZ0700201 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2007-10-22 | SmithKline Beecham plc | Smithkline Beecham Plc | Certificate Issued | 2008-08-12 | view |
| CYHS1100813 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2011-11-10 | 山西普德药业股份有限公司 | Shanxi PUDE Pharmaceutical Co Ltd | Certificate Issued | 2017-02-13 | view |
| JYHB1800404 | 注射用盐酸托泊替康 | topotecan hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2018-04-08 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2018-04-17 | view |
